Create the AI Future: TECNO Unveils Next-Gen AI Ecosystem at MWC Barcelona 2025
TECNO will showcase its cutting-edge AI ecosystem,delivering practical AI solutions tailored for emerging markets. Highlights include the debut of the CAMON 40 imaging flagship smartphone,next-genera
DEKRA Successfully Showcases Cutting-Edge Safety and Innovation at ELECRAMA 2025
NEW DELHI,March 4,2025-- DEKRA has successfully concluded its participation at ELECRAMA 2025,the premier event organized by the Indian Electrical & Electronics Manufacturers\' Association (IEEMA)
Ping An Enhances Recruitment Experience with "Ping An Talent" AI System
HONG KONG and SHANGHAI,March 4,2025--Ping An Insurance (Group) Company of China,Ltd. (hereafter "Ping An","the Company"or the "Group"HKEX: 2318 / 82318; SSE: 601318) rece
Small Battery, Big Power: SUNGROW Unveils SBS050 5 kWh Home Battery
HEFEI,China,March 4,2025--Recently,SUNGROW unveiled its 5 kWh SBS050 home energy storage battery,a game-changing solution that redefines residential energy storage. With a compact 182 mm design,SBS05
HONOR Introduces the Ultra-thin HONOR Pad V9 at MWC 2025
BARCELONA,Spain,March 3,2025-- HONOR today announced the HONOR ALPHA PLAN,a new corporate strategy to transform HONOR from a smartphone maker to a global leading AI device ecosystem company. Funded b
BARCELONA,Spain,March 3,2025-- TCL,a pioneer in display across feature-rich smartphones,tablets,and connected devices,today expanded its TCL 60 series with the introduction of six additional smartphon
ESR Unveils Upgraded Digital Presence Reflecting Its Focus on Innovation and Technology
Transformation fromESR Gear to ESR Tech further advances the mission of "Tech Made Easier",enhancing everyday tech experiences with innovative solutions
Paeonia Industries Announces Acquisition of the Savant Group of companies
MIDLAND,Mich.,March 3,2025-- Paeonia Industries,a premier global firm with deep roots in analytical equipment manufacturing for energy testing,as well as the distribution of scientific testing instrum
SUZHOU,China,March 4,2025--CStone Pharmaceuticals ("CStone",HKEX: 2616),an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies,today
STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2]